Quantitative LC/MS/MS Analysis of Drugs in Human Serum With Agilent Captiva EMR–Lipid Cleanup

Applications | 2017 | Agilent TechnologiesInstrumentation
Sample Preparation, Consumables, LC/MS, LC/MS/MS, LC/QQQ
Industries
Clinical Research
Manufacturer
Agilent Technologies
Go to the libraryView PDF
Downloadable PDF for viewing
 

Similar PDF

Enhanced Lipids Removal From Biological Matrices to Prepare Samples for LC/MS/MS Analysis
Enhanced Lipids Removal From Biological Matrices to Prepare Samples for LC/MS/MS Analysis
2017|Agilent Technologies|Posters
Quantitative Determination of Drugs of Abuse in Human Whole Blood by LC/MS/MS Using Agilent Captiva EMR—Lipid Cleanup
Quantitative Determination of Drugs of Abuse in Human Whole Blood by LC/MS/MS Using Agilent Captiva EMR—Lipid Cleanup
2018|Agilent Technologies|Applications
Quantitative Determination of Drugs of Abuse in Human Plasma and Serum by LC/MS/MS Using Agilent Captiva EMR—Lipid Cleanup
Quantitative Determination of Drugs of Abuse in Human Plasma and Serum by LC/MS/MS Using Agilent Captiva EMR—Lipid Cleanup
2018|Agilent Technologies|Applications
A Comprehensive Workflow for a Large Panel of Drugs of Abuse in Human Whole Blood by LC/MS/MS
A Comprehensive Workflow for a Large Panel of Drugs of Abuse in Human Whole Blood by LC/MS/MS
2020|Agilent Technologies|Applications